Aimei Health Technology Co., Ltd (AFJK)

Aimei Health Technology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	1.41	2.55	0.26
Other Operating Activities	-2.39	-3.62	-0.3
Change in Other Net Operating Assets	0.27	0.39	0.04
Operating Cash Flow	-0.72	-0.67	-
Other Investing Activities	29.61	-0.28	-104.54
Investing Cash Flow	29.61	-0.28	-104.54
Short-Term Debt Issued	-	0.4	-
Total Debt Issued	2.27	0.4	0.31
Total Debt Repaid	-	-	-0.32
Net Debt Issued (Repaid)	2.27	0.4	-0.01
Issuance of Common Stock	-	-	108.52
Other Financing Activities	-	-	-3.11
Financing Cash Flow	-28.99	0.4	105.41
Net Cash Flow	-0.1	-0.55	0.87
Levered Free Cash Flow	0.27	-0.1	-
Unlevered Free Cash Flow	0.27	-0.1	-
Change in Working Capital	0.27	0.39	0.04

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q